Max Ellinger Archive

A man in a white polo shirt smiles at the camera next to text reading
Staff Spotlight: Chase Hanna
A man in a white lab coat with a
Big-data longevity specialist boosts HonorHealth Research Institute’s efforts to help patients lead longer, more productive lives
A woman smiling in front of a gray backdrop beside text that reads
Staff Spotlight: Brooke Gillespie
A man wearing glasses, a gray suit, blue shirt, and patterned tie poses for a professional portrait against a plain gray background.
HonorHealth Research Institute presents ‘monumental’ increase in survivability for patients suffering ultra-low blood pressure
A person stands in a medical lab, wearing a black vest and gesturing with their hands. Medical equipment, monitors, and a hospital bed are visible in the background.
HonorHealth Research Institute is helping give brain stroke victims a chance at improved recoveries thanks to data-driven medical care
A person with long red hair, wearing a grey blazer over a white blouse, poses and smiles in front of a mottled blue background.
First patient in the world treated for muscle-weakness disease in clinical trial at HonorHealth Research Institute
A man in a dark suit and purple tie stands indoors, smiling at the camera. The background is softly blurred.
‘Magnificent 7’ combo treatment for pancreatic cancer presented at international forum by HonorHealth Research Institute
A building with a stone facade displays a sign that reads
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of WTX-124
Two scientists in lab coats work in a laboratory; one operates a pipette while the other observes. Laboratory equipment and supplies are visible in the background.
HonorHealth Research Institute will present new findings in decades-long quest to conquer aggressive pancreatic cancer
Five people, three men and two women, stand in a line indoors, wearing business and medical attire, smiling at the camera.
HonorHealth Research Institute is the first of 50 sites worldwide to treat a patient in a new clinical study aimed at melanoma